Trial Profile
Immunogenicity and Safety of Three Consecutive Lots of a New Inactivated Enterovirus Type 71 (EV71) Vaccine: A Double-blind, Randomized and Controlled Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Mar 2014
Price :
$35
*
At a glance
- Drugs Enterovirus A vaccine (Primary)
- Indications Coxsackievirus infections; Enterovirus A infections
- Focus Pharmacodynamics; Registrational
- Sponsors Sinovac Biotech
- 26 Feb 2014 Results have been published online in the October 2013 issue of the Clinical and Vaccine Immunology according to a Sinovac Biotech media release.
- 14 Mar 2013 Results published in a Sinovac Biotech media release.
- 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.